201 related articles for article (PubMed ID: 28824731)
1. Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis.
Guiot J; Struman I; Chavez V; Henket M; Herzog M; Scoubeau K; Hardat N; Bondue B; Corhay JL; Moermans C; Louis R
Clin Epigenetics; 2017; 9():84. PubMed ID: 28824731
[TBL] [Abstract][Full Text] [Related]
2. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respirology; 2020 Mar; 25(3):275-280. PubMed ID: 31270920
[TBL] [Abstract][Full Text] [Related]
3. Pre-analytical variables of circulating cell-free nucleosomes containing 5-methylcytosine DNA or histone modification H3K9Me3.
Rasmussen L; Herzog M; Rømer E; Micallef J; Bulut O; Wilhelmsen M; Christensen IJ; Nielsen HJ
Scand J Clin Lab Invest; 2016 Oct; 76(6):448-53. PubMed ID: 27291394
[TBL] [Abstract][Full Text] [Related]
4. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
[TBL] [Abstract][Full Text] [Related]
5. Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis.
Guiot J; Bondue B; Henket M; Corhay JL; Louis R
BMC Pulm Med; 2016 May; 16(1):86. PubMed ID: 27215343
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis.
Min H; Fan S; Song S; Zhuang Y; Li H; Wu Y; Cai H; Yi L; Dai J; Gao Q
Diagn Pathol; 2016 Nov; 11(1):135. PubMed ID: 27881157
[TBL] [Abstract][Full Text] [Related]
7. Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.
White ES; Xia M; Murray S; Dyal R; Flaherty CM; Flaherty KR; Moore BB; Cheng L; Doyle TJ; Villalba J; Dellaripa PF; Rosas IO; Kurtis JD; Martinez FJ
Am J Respir Crit Care Med; 2016 Nov; 194(10):1242-1251. PubMed ID: 27149370
[TBL] [Abstract][Full Text] [Related]
8. Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis.
Maldonado M; Buendía-Roldán I; Vicens-Zygmunt V; Planas L; Molina-Molina M; Selman M; Pardo A
PLoS One; 2018; 13(9):e0203779. PubMed ID: 30208119
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis.
Velagacherla V; Mehta CH; Nayak Y; Nayak UY
Life Sci; 2022 Feb; 291():120283. PubMed ID: 34998839
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
11. S100A9/CD163 expression profiles in classical monocytes as biomarkers to discriminate idiopathic pulmonary fibrosis from idiopathic nonspecific interstitial pneumonia.
Yamashita M; Utsumi Y; Nagashima H; Nitanai H; Yamauchi K
Sci Rep; 2021 Jun; 11(1):12135. PubMed ID: 34108546
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.
Todd JL; Neely ML; Overton R; Durham K; Gulati M; Huang H; Roman J; Newby LK; Flaherty KR; Vinisko R; Liu Y; Roy J; Schmid R; Strobel B; Hesslinger C; Leonard TB; Noth I; Belperio JA; Palmer SM;
Respir Res; 2019 Oct; 20(1):227. PubMed ID: 31640794
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis.
Hata A; Nakajima T; Matsusaka K; Fukuyo M; Nakayama M; Morimoto J; Ito Y; Yamamoto T; Sakairi Y; Rahmutulla B; Ota S; Wada H; Suzuki H; Iwata T; Matsubara H; Ohara O; Yoshino I; Kaneda A
Int J Cancer; 2021 Jun; 148(12):3008-3018. PubMed ID: 33533494
[TBL] [Abstract][Full Text] [Related]
14. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
[TBL] [Abstract][Full Text] [Related]
15. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
[TBL] [Abstract][Full Text] [Related]
16. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.
Conforti F; Davies ER; Calderwood CJ; Thatcher TH; Jones MG; Smart DE; Mahajan S; Alzetani A; Havelock T; Maher TM; Molyneaux PL; Thorley AJ; Tetley TD; Warner JA; Packham G; Ganesan A; Skipp PJ; Marshall BJ; Richeldi L; Sime PJ; O'Reilly KMA; Davies DE
Oncotarget; 2017 Jul; 8(30):48737-48754. PubMed ID: 28467787
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics in lung fibrosis: from pathobiology to treatment perspective.
Helling BA; Yang IV
Curr Opin Pulm Med; 2015 Sep; 21(5):454-62. PubMed ID: 26176965
[TBL] [Abstract][Full Text] [Related]
19. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis.
Casoni GL; Ulivi P; Mercatali L; Chilosi M; Tomassetti S; Romagnoli M; Ravaglia C; Gurioli C; Gurioli C; Zoli W; Silvestrini R; Poletti V
Int J Biol Markers; 2010; 25(4):229-35. PubMed ID: 21161945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
